Report : A-Z CDF items in Formulary 23/09/2020 00:45:33

[Back]

Section Status CDF Name 08.01.05 Formulary Aflibercept infusion Zaltrap® 08.01.01 Restricted Use Bendamustine infusion  08.01.05 Restricted Use Bevacizumab  08.01.05 Restricted Use Bortezomib injection  08.01.05 Restricted Use Bosutinib  08.01.05 Restricted Use Brentuximab vedotin  08.01.05 Restricted Use Cabozantinib tabs Cabometyx® 08.01.05 Restricted Use Cetuximab  08.01.03 Non Formulary Clofarabine  08.01.05 Restricted Use Crizotinib  08.01.05 Restricted Use Dabrafenib caps  08.02.04 Restricted Use Daratumumab injection  08.01.05 Restricted Use Dasatinib  08.01.02 Restricted Use Doxorubicin pegylated liposomal Caelyx® 08.01.05 Restricted Use Eribulin  08.01.05 Restricted Use Everolimus Afinitor® 08.01.05 Restricted Use Ibrutinib  08.01.05 Restricted Use Idelalisib tabs  08.01.05 Restricted Use Ipilimumab  08.01.05 Formulary Ixazomib  08.02.04 Restricted Use Lenalidomide caps  08.01.03 Non Formulary Nelarabine Atriance® 08.01.05 Restricted Use Nivolumab injection  08.01.05 Restricted Use Osimertinib tab  08.01.05 Restricted Use Panitumumab  08.01.03 Restricted Use Pemetrexed  08.01.05 Restricted Use Pertuzumab injection  08.02.04 Restricted Use Pomalidomide  08.01.05 Restricted Use Ponatinib  08.03.04.02 Restricted Use Radium-223 dichloride  08.01.05 Formulary Regorafenib tab  08.01.05 Restricted Use Sorafenib tabs  08.01.05 Restricted Use Sunitinib  08.01.05 Non Formulary Temsirolimus  08.01.05 Restricted Use Trametinib tabs  08.01.05 Restricted Use Trastuzumab emtansine Kadcyla® 08.01.05 Non Formulary Vandetanib tabs  08.01.05 Restricted Use Vismodegib

North Central London